code,company,date,text
ABBV,AbbVie Inc,2019-04-24,The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug  Novartis Earnings  Patent Notification For MediciNova
ABBV,AbbVie Inc,2019-04-24,AbbVie stock ticks higher on FDA approval of psoriasis treatment
ABBV,AbbVie Inc,2019-04-24,AbbVie psoriasis treatment Skyrizi gets FDA approval
ABBV,AbbVie Inc,2019-04-22,Better Buy: Biogen vs. AbbVie
ABBV,AbbVie Inc,2019-04-22,AbbVie Reports Its Q1 Results on Thursday: Here's What You Can Expect
ABBV,AbbVie Inc,2019-04-20,3 Cancer Treatment Stocks to Buy in April
ABBV,AbbVie Inc,2019-04-19,5 Top Pharmaceutical Stocks to Buy in 2019
ABBV,AbbVie Inc,2019-04-19,5 Top Biotech Stocks to Buy in 2019
ABBV,AbbVie Inc,2019-04-19,5 Top Healthcare Stocks to Buy in 2019
ABBV,AbbVie Inc,2019-04-17,AbbVie Falls 3%
ABBV,AbbVie Inc,2014-07-14,U.S. futures rise as sentiment improves; Dow Jones up 0.33%
ABBV,AbbVie Inc,2014-07-14,Shire Ready To Recommend AbbVie's $53B Offer
ABBV,AbbVie Inc,2014-07-14,European stocks rise as Portugal concerns ease; Dax up 0.45%
ABBV,AbbVie Inc,2014-07-09,U.S. stocks rise as markets turn to Fed minutes; Dow Jones up 0.34%
ABBV,AbbVie Inc,2014-07-09,U.S. futures hold steady ahead of Fed minutes; Dow Jones down 0.06%
ABBV,AbbVie Inc,2014-06-30,U.S. stocks open mixed ahead of data; Dow Jones down 0.22%
ABBV,AbbVie Inc,2014-06-30,European stocks erase gains after inflation report; Dax down 0.02%
ABBV,AbbVie Inc,2014-06-30,U.S. futures little changed amid Fed hopes; Dow Jones down 0.07%
ABBV,AbbVie Inc,2014-06-30,Global M&A at seven-year high as big corporate deals return
ABBV,AbbVie Inc,2014-06-30,European stocks rise ahead of inflation data; Dax up 0.66%
ABBV,AbbVie Inc,2014-08-06,Walgreen retreats from plan to move tax domicile abroad 
ABBV,AbbVie Inc,2014-07-30,Ireland has too much to lose to deter U.S. companies re-homing
ABBV,AbbVie Inc,2014-07-28,Hospira Aspires To Save On Taxes With $5B Danone Deal: Reports
ABBV,AbbVie Inc,2014-07-18,U.S. drugmaker AbbVie finally wins Dublin's Shire with $55 billion deal
ABBV,AbbVie Inc,2014-07-17,Shire  AbbVie to announce $53 billion merger by Friday: sources
ABBV,AbbVie Inc,2014-07-16,Obama Government Seeks Legislation To Curb Corporate Tax Flight
ABBV,AbbVie Inc,2014-07-14,Shire ready to bow to AbbVie's increased $53 billion offer
ABBV,AbbVie Inc,2014-07-14,Wall Street opens up on M&A  Citi earnings
ABBV,AbbVie Inc,2014-07-14,U.S. stocks open higher in risk-on trade; Dow Jones up 0.59%
ABBV,AbbVie Inc,2014-07-14,European stocks hold gains despite weak E.Z. data; Dax up 0.76%
ABBV,AbbVie Inc,2014-10-20,Exclusive: Allergan shareholder Paulson & Co urges deal with Shire - sources
ABBV,AbbVie Inc,2014-10-16,AbbVie board ditches planned $55 billion Shire acquisition
ABBV,AbbVie Inc,2014-10-15,Bond yields  oil prices fall as gloom persists
ABBV,AbbVie Inc,2014-10-15,European stocks slide lower as data still weighs; Dax down 0.10%
ABBV,AbbVie Inc,2014-10-05,Becton Dickinson to buy CareFusion for $12 billion in cash  stock
ABBV,AbbVie Inc,2014-09-23,Shares of 'inversion' candidates slide on U.S. tax rule
ABBV,AbbVie Inc,2014-09-23,AstraZeneca  Shire dive as U.S. tax move punctures deal hopes
ABBV,AbbVie Inc,2014-09-03,Google's Calico  AbbVie forge deal against diseases of aging
ABBV,AbbVie Inc,2014-08-24,Burger King  Tim Horton's May Merge
ABBV,AbbVie Inc,2014-08-06,Walgreen to keep U.S. tax domicile after buying Alliance Boots
ABBV,AbbVie Inc,2014-12-24,United States stocks mixed at close of trade
ABBV,AbbVie Inc,2014-12-23,Exclusive: Express Scripts presses for more drug savings with coverage list 
ABBV,AbbVie Inc,2014-12-22,Dow  S&P end at records in fourth straight day of gains for Wall Street
ABBV,AbbVie Inc,2014-12-10,Shire CEO eyes deals  but no urgency to spend AbbVie breakup fee
ABBV,AbbVie Inc,2014-11-14,AstraZeneca not only game in town for deal-hungry Pfizer
ABBV,AbbVie Inc,2014-10-31,AbbVie says strong results lessen need for big deal
ABBV,AbbVie Inc,2014-10-29,U.S. law firm says investigating AbbVie over collapsed Shire deal
ABBV,AbbVie Inc,2014-10-28,Pfizer beats sales and profit forecasts  mum on future deals
ABBV,AbbVie Inc,2014-10-21,European stocks steady to higher in choppy trade; Dax up 0.11%
ABBV,AbbVie Inc,2014-10-20,AbbVie says $55 billion acquisition of Shire officially dead
ABBV,AbbVie Inc,2015-03-05,U.S. stocks higher at close of trade
ABBV,AbbVie Inc,2015-03-05,Wall Street closes up slightly ahead of jobs report
ABBV,AbbVie Inc,2015-03-05,U.S. stock markets avoid first three-day losing streak since early-January
ABBV,AbbVie Inc,2015-03-05,AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
ABBV,AbbVie Inc,2015-03-05,AbbVie To Acquire Cancer Drugmaker Pharmacyclics For $21B 
ABBV,AbbVie Inc,2015-01-15,Insight: Big Pharma faces up to new price pressure from aggressive insurers
ABBV,AbbVie Inc,2015-01-11,Shire to buy NPS for $5.2 billion to boost rare disease drugs
ABBV,AbbVie Inc,2015-01-08,Wall St. jumps for second day  helped by economic optimism
ABBV,AbbVie Inc,2015-01-05,Energy shares lead Wall Street to worst day since early October
ABBV,AbbVie Inc,2014-12-28,Elder-care challenges prompt tech executives to create startups  apps
ABBV,AbbVie Inc,2015-10-12,Exclusive - Transatlantic divide: how U.S. pays three times more for drugs
ABBV,AbbVie Inc,2015-09-28,Democrats take aim at drug prices  prompting sharp drops in biotech stocks
ABBV,AbbVie Inc,2015-09-18,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.74%
ABBV,AbbVie Inc,2015-08-13,Shire seen having wiggle room on price in $30 billion Baxalta battle
ABBV,AbbVie Inc,2015-08-04,Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
ABBV,AbbVie Inc,2015-07-27,Teva to buy Allergan generic business for $40.5 billion  drops Mylan bid
ABBV,AbbVie Inc,2015-07-24,AbbVie reports first revenue miss in six quarters
ABBV,AbbVie Inc,2015-05-04,Greenlight's Einhorn slams oil frackers at Sohn conference
ABBV,AbbVie Inc,2015-04-21,Generic drugmaker Teva makes $40 billion offer for rival Mylan
ABBV,AbbVie Inc,2015-04-14,Banks see talent flee amid healthcare M&A boom
ABBV,AbbVie Inc,2016-02-01,Abbott Labs to buy diagnostics company Alere for $5.8 billion
ABBV,AbbVie Inc,2016-01-29,Wall St. up as weak GDP spurs hope of slower rate hikes
ABBV,AbbVie Inc,2016-01-11,Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
ABBV,AbbVie Inc,2015-12-17,AstraZeneca buys most of Acerta for $4 billion to add cancer drug
ABBV,AbbVie Inc,2015-11-20,Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
ABBV,AbbVie Inc,2015-11-02,Wall St. climbs  led by energy  healthcare; Nasdaq 100 hits 15-year high
ABBV,AbbVie Inc,2015-10-30,Exclusive: Beyond Valeant  U.S. payers scrutinize other drugmaker ties to pharmacies
ABBV,AbbVie Inc,2015-10-30,Stocks slip but post best month in four years 
ABBV,AbbVie Inc,2015-10-30,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.52%
ABBV,AbbVie Inc,2015-10-22,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.87%
ABBV,AbbVie Inc,2016-05-17,Wall Street lower as strong data raises chances of rate hike 
ABBV,AbbVie Inc,2016-05-04,Slower growth dominates picks at hedge fund conference
ABBV,AbbVie Inc,2016-05-04,Biotech stock swoon sparks buyout interest: investor
ABBV,AbbVie Inc,2016-04-28,AbbVie forges deeper into cancer  as clock ticks for Humira
ABBV,AbbVie Inc,2016-04-06,Pfizer  Allergan scrap $160 billion deal after U.S. tax rule change
ABBV,AbbVie Inc,2016-04-06,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
ABBV,AbbVie Inc,2016-04-05,Deja vu for Paulson as Allergan loss hurts U.S. hedge funds
ABBV,AbbVie Inc,2016-03-11,European stocks open sharply higher on ECB stimulus; Dax up 2.11%
ABBV,AbbVie Inc,2016-02-23,CVS says 2015 drug spending grew 5 percent  far less than in 2014
ABBV,AbbVie Inc,2016-02-03,Seven $1 billion-plus drugs seen reaching market in 2016
ABBV,AbbVie Inc,2016-11-16,Regeneron and Sanofi's sarilumab beats AbbVie's Humira in late-stage RA study
ABBV,AbbVie Inc,2016-11-15,AbbVie's pan-genotypic regimen of glecaprevir/pibrentasvir shows 98% cure rate in late-stage study in HCV-positive patients with chronic kidney disease
ABBV,AbbVie Inc,2016-11-13,Merck's triple combo HCV candidate achieves cure rates as high as 100% in mid-stage studies
ABBV,AbbVie Inc,2016-11-12,J&J arthritis drug has mixed results against incumbents
ABBV,AbbVie Inc,2016-11-11,AbbVie's next-generation pan-genotypic HCV regimen shows cure rates as high as 99% after eight weeks
ABBV,AbbVie Inc,2016-11-09,Biotechs love Trump  many ahead premarket
ABBV,AbbVie Inc,2016-11-07,Patent Office denies Coherus Bio's petition for review of AbbVie Humira patent; shares down 11%
ABBV,AbbVie Inc,2016-09-19,GE brings off-the-shelf biotech drug factories to Ireland
ABBV,AbbVie Inc,2016-08-22,Pfizer boosts cancer drug roster with $14 billion Medivation deal
ABBV,AbbVie Inc,2016-06-06,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.64%
ABBV,AbbVie Inc,2017-04-18,J&J's 3.4% post-earnings decline leads healthcare lower; UNH a rare gainer
ABBV,AbbVie Inc,2017-04-10,Goldman: 21 stocks seen lifting margins
ABBV,AbbVie Inc,2017-04-07,AbbVie's elagolix reduces heavy menstrual bleeding in mid-stage uterine fibroid study; shares ahead 2% premarket
ABBV,AbbVie Inc,2017-03-10,Wall Street trims gains as jobs data paves Fed path to hike rates
ABBV,AbbVie Inc,2017-01-27,Merck reveals seven years of its U.S. drug price increase history
ABBV,AbbVie Inc,2017-01-27,AbbVie's revenue misses as Hepatitis C  cancer drugs drag
ABBV,AbbVie Inc,2017-01-12,Pharma company executives debate drug pricing increases
ABBV,AbbVie Inc,2016-12-27,Abbott gets U.S. antitrust approval to buy St. Jude Medical
ABBV,AbbVie Inc,2016-12-22,Exclusive: U.S. regulator poised to approve Abbott purchase of St Jude - sources
ABBV,AbbVie Inc,2016-11-29,Health stocks boost Wall Street; energy a drag
ABBV,AbbVie Inc,2017-06-13,AbbVie and Principia Bio team up to develop oral immunoproteasome inhibitors
ABBV,AbbVie Inc,2017-06-09,Illinois court finds AbbVie liable for birth defects related to Depakote  $15M in compensatory damages
ABBV,AbbVie Inc,2017-05-18,AbbVie: 23 abstracts to be presented at ASCO
ABBV,AbbVie Inc,2017-05-17,Premarket Gainers as of 9:10 am
ABBV,AbbVie Inc,2017-05-17,Coherus prevails in challenge to AbbVie Humira patent; shares ahead 8% premarket
ABBV,AbbVie Inc,2017-05-11,U.S. hepatitis C cases soar on spike in heroin use
ABBV,AbbVie Inc,2017-05-09,Sanofi pegs U.S. drug price rises to below healthcare inflation
ABBV,AbbVie Inc,2017-05-04,AbbVie to present data on Crohn's disease studies
ABBV,AbbVie Inc,2017-04-26,Notable earnings before Thursday’s open
ABBV,AbbVie Inc,2017-04-24,NASH: The next untapped pharma market gives investors many options
ABBV,AbbVie Inc,2017-09-05,FDA Orphan Drug update
ABBV,AbbVie Inc,2017-08-03,FDA OKs AbbVie's pan-genotypic HCV med Mavyret
ABBV,AbbVie Inc,2017-07-28,AbbVie's profit beats on Humira  Imbruvica demand
ABBV,AbbVie Inc,2017-07-28,U.S. futures point to lower open as tech rally stalls
ABBV,AbbVie Inc,2017-07-28,Top 5 things to know in the market on Friday
ABBV,AbbVie Inc,2017-07-27,Notable earnings before Friday’s open
ABBV,AbbVie Inc,2017-07-19,Vertex Pharma shares hit life high as cystic fibrosis data wows
ABBV,AbbVie Inc,2017-06-29,CytomX poised to receive $15M milestone from partner AbbVie on advancement of cancer candidate CX-2029
ABBV,AbbVie Inc,2017-06-23,European Ad Comm backs AbbVie's G/P eight-week HCV combo pill
ABBV,AbbVie Inc,2017-06-21,Biotechs blaze as Trump draft order on drug prices would ease regulations
ABBV,AbbVie Inc,2017-09-28,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.18%
ABBV,AbbVie Inc,2017-09-28,Wall St. edges up on healthcare  tax plan hopes
ABBV,AbbVie Inc,2017-09-28,Stocks – Wall Street Trades Mixed Despite Upward GDP Revision
ABBV,AbbVie Inc,2017-09-21,"FDA's Woodcock says clinical trials system ""broken"""
ABBV,AbbVie Inc,2017-09-15,Marijuana Stocks are Smoking Hot 
ABBV,AbbVie Inc,2017-09-08,U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.06%
ABBV,AbbVie Inc,2017-09-08,AbbVie declares $0.64 dividend
ABBV,AbbVie Inc,2017-09-07,Wall St. ends flat as media stocks slump  healthcare gains
ABBV,AbbVie Inc,2017-09-07,U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10%
ABBV,AbbVie Inc,2017-09-07,AbbVie shares rally on positive eczema study  competitor Regeneron drops
ABBV,AbbVie Inc,2017-10-26,AbbVie's risankizumab beats Humira and Stelara in late-stage psoriasis studies; investors unmoved  shares down 5%
ABBV,AbbVie Inc,2017-10-24,Big pharma/biotech players under pressure  Valeant only bright spot
ABBV,AbbVie Inc,2017-10-18,AbbVie teams up with Harpoon Therapeutics in immuno-oncology; shares up 1% premarket
ABBV,AbbVie Inc,2017-10-16,"President Trump at it again with comments on ""out of control"" drug prices"
ABBV,AbbVie Inc,2017-10-16,TG Therapeutics down 20% premarket on potential extended timeline for U.S. marketing application for lead candidate TG-1101
ABBV,AbbVie Inc,2017-10-10,California enacts law aimed at corralling high drug prices
ABBV,AbbVie Inc,2017-10-09,California governor signs drug pricing transparency law
ABBV,AbbVie Inc,2017-10-09,China to accept out-of-country trial data to speed up drug approvals
ABBV,AbbVie Inc,2017-10-02,Texas court strikes down Treasury Department's inversion law
ABBV,AbbVie Inc,2017-10-02,Med stocks up early  biotechs lead
ABBV,AbbVie Inc,2018-01-08,Start of JPM18 fails to buoy healthcare stocks
ABBV,AbbVie Inc,2018-01-08,AbbVie's upadacitinib nabs accelerated review status in U.S. for atopic dermatitis
ABBV,AbbVie Inc,2018-01-02,U.S. drug approvals highest in 21 years
ABBV,AbbVie Inc,2017-12-30,Stocks to watch next week
ABBV,AbbVie Inc,2017-12-23,Stocks to watch next week
ABBV,AbbVie Inc,2017-12-04,AbbVie's risankizumab successful in fourth late-stage psoriasis study
ABBV,AbbVie Inc,2017-11-28,Premarket analyst action - healthcare
ABBV,AbbVie Inc,2017-11-28,Legality of patent reviews?
ABBV,AbbVie Inc,2017-11-27,Supreme Court divided over legality of patent reviews
ABBV,AbbVie Inc,2017-11-21,Galapagos launches early-stage study of GLPG3221 in cystic fibrosis  earns $10M milestone from AbbVie
ABBV,AbbVie Inc,2018-01-30,Pfizer sees upbeat 2018 on lower tax rate  shares dip after highs
ABBV,AbbVie Inc,2018-01-30,Height weighs in on Amazon/Berkshire/JPMorgan healthcare venture
ABBV,AbbVie Inc,2018-01-26,AbbVie wins U.S. trial in lawsuit over AndroGel's risks
ABBV,AbbVie Inc,2018-01-26,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.85%
ABBV,AbbVie Inc,2018-01-26,Intel  healthcare shares boost lift Wall St. to record
ABBV,AbbVie Inc,2018-01-26,Big biopharma in the green after AbbVie's Q4 beat
ABBV,AbbVie Inc,2018-01-24,Profit-taking weighs on biotechs and biopharmas
ABBV,AbbVie Inc,2018-01-19,Key events next week - healthcare
ABBV,AbbVie Inc,2018-01-16,FDA launches new program to boost transparency of clinical data used to support approvals
ABBV,AbbVie Inc,2018-01-10,AbbVie chief upbeat on prospects  sees $21B in sales in 2020
ABBV,AbbVie Inc,2018-04-03,CMS finalizes policies to reduce drug costs for Medicare beneficiaries
ABBV,AbbVie Inc,2018-03-28,FDA working on policies to boost biosimilars
ABBV,AbbVie Inc,2018-03-26,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.84%
ABBV,AbbVie Inc,2018-03-25,Singapore pharma on recovery path after worst output in decades
ABBV,AbbVie Inc,2018-03-22,Stocks tumble to worst day in six weeks after Trump tariff action
ABBV,AbbVie Inc,2018-03-22,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.93%
ABBV,AbbVie Inc,2018-02-16,AbbVie's JAK1 inhibitor upadacitinib shows durable treatment effect in mid-stage Crohn's study; shares up 3%
ABBV,AbbVie Inc,2018-02-15,AbbVie to buy back $10 billion of shares  raises dividend
ABBV,AbbVie Inc,2018-01-31,Big biopharma firms poised to end session in the red after Trump comments on high prices
ABBV,AbbVie Inc,2018-01-30,AbbVie  Lilly particularly vulnerable to BRK/AMZN/JPM venture - BMO
ABBV,AbbVie Inc,2018-04-30,Corporate America Is Saving Boatloads on Trump Tax-Cut Windfall
ABBV,AbbVie Inc,2018-04-25,Notable earnings before Thursday’s open
ABBV,AbbVie Inc,2018-04-24,Shire says willing to recommend Takeda's $64 billion offer to shareholders
ABBV,AbbVie Inc,2018-04-24,U.S. Supreme Court upholds legality of patent review process
ABBV,AbbVie Inc,2018-04-23,Amid drug price worries  earnings to test U.S. pharma  biotech shares
ABBV,AbbVie Inc,2018-04-19,Novartis Q1 results weigh on pharma stocks
ABBV,AbbVie Inc,2018-04-19,U.S. opioid prescriptions down 12% last year  largest drop in 25 years
ABBV,AbbVie Inc,2018-04-18,Shire faces criticism on CEO pay policy as crunch week looms
ABBV,AbbVie Inc,2018-04-09,Samsung C&T mulling raising up to $2.8 bln to buy stake in biopharma affiliate: MBC
ABBV,AbbVie Inc,2018-04-04,Oryzon Genomics on go with mid-stage study of Alzheimer's candidate ORY-2001
ABBV,AbbVie Inc,2018-05-31,FDA issues draft guidance aimed at easing regulatory path for generic drugs
ABBV,AbbVie Inc,2018-05-30,Premarket analyst action - healthcare
ABBV,AbbVie Inc,2018-05-18,Investors bullish on biotechs after Trump drug pricing speech
ABBV,AbbVie Inc,2018-05-16,Biotechs perk up ahead of ASCO abstract drop
ABBV,AbbVie Inc,2018-05-15,Glenview added Express Scripts  exited Apple in Q1
ABBV,AbbVie Inc,2018-05-14,Oryzon Genomics commences mid-stage study of Alzheimer's candidate
ABBV,AbbVie Inc,2018-05-11,Trump speech on drug prices light on specifics
ABBV,AbbVie Inc,2018-05-11,Trump plan on drug prices to be announced this afternoon
ABBV,AbbVie Inc,2018-05-01,Pfizer first-quarter results miss estimates as key drug sales fall short
ABBV,AbbVie Inc,2018-05-01,Premarket Gainers as of 9:05 am (05/01/2018)
ABBV,AbbVie Inc,2018-07-11,Big Pharma in the red after Pfizer backs away from price hikes
ABBV,AbbVie Inc,2018-07-10,Pricing transparency law in California having effect  drug makers nix planned increases
ABBV,AbbVie Inc,2018-07-09,Biotechs give up gains after Trump tweet on prices
ABBV,AbbVie Inc,2018-07-06,Alzheimer's players in the green on Biogen news
ABBV,AbbVie Inc,2018-07-05,Drugmakers try evasion  tougher negotiations to fight new U.S. insurer tactic
ABBV,AbbVie Inc,2018-06-29,AbbVie  AndroGel partner owe $448 million in antitrust case: U.S. judge
ABBV,AbbVie Inc,2018-06-22,AbbVie's Humira could face pressure from biosimilars  analyst says
ABBV,AbbVie Inc,2018-06-18,How U.S. tax reform rewards companies that shift profit to tax havens
ABBV,AbbVie Inc,2018-06-05,AbbVie's upadacitinib successful in another late-stage RA study
ABBV,AbbVie Inc,2018-06-01,Premarket analyst action - healthcare
ABBV,AbbVie Inc,2018-10-11,AbbVie Falls 4%
ABBV,AbbVie Inc,2018-10-03,Trio wins chemistry Nobel for work on antibody drugs  smart enzymes
ABBV,AbbVie Inc,2018-09-24,FDA on board with design of pivotal study for Eiger's pegylated interferon-alfa; shares up 5%
ABBV,AbbVie Inc,2018-09-18,AbbVie Falls 3.03%
ABBV,AbbVie Inc,2018-09-13,AbbVie Rises 3.02%
ABBV,AbbVie Inc,2018-08-23,Oklahoma first state to negotiate efficacy-based drug prices
ABBV,AbbVie Inc,2018-08-22,European shares open cautiously after Wall Street's record high
ABBV,AbbVie Inc,2018-07-24,Citron's Left reiterates belief AbbVie shares will fall sharply
ABBV,AbbVie Inc,2018-07-17,AbbVie out-licenses Humira patents to Mylan  biosimilar sales five years away in U.S.
ABBV,AbbVie Inc,2018-07-16,CVS responds to Trump Administration's request for info on now to lower drug prices
ABBV,AbbVie Inc,2018-10-31,AbbVie rheumatoid arthritis drug succeeds in late stage trial
ABBV,AbbVie Inc,2018-10-31,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-10-26,Abbott and AbbVie to pay $25M to settle TriCor case
ABBV,AbbVie Inc,2018-10-25,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-10-24,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-10-22,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-10-18,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-10-18,AbbVie teams up with Morphic Therapeutic in fibrotic diseases
ABBV,AbbVie Inc,2018-10-16,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-10-15,FDA issues new guidance aimed at more efficient drug development
ABBV,AbbVie Inc,2018-11-13,Walmart  Home Depot adopt health insurer tactic in drug copay battle
ABBV,AbbVie Inc,2018-11-08,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-11-07,Health stocks up on U.S. vote; insurers hit records
ABBV,AbbVie Inc,2018-11-07,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-11-05,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-11-02,Stocks - Apple  Kraft  GoPro Plunge in Pre-market; Starbucks  Exxon  Boeing Jump
ABBV,AbbVie Inc,2018-11-02,AbbVie lifts profit target after cancer drug powers third-quarter beat
ABBV,AbbVie Inc,2018-11-02,AbbVie Earnings  Revenue beat in Q3
ABBV,AbbVie Inc,2018-11-01,Notable earnings before Friday’s open
ABBV,AbbVie Inc,2018-11-01,AbbVie's Leukemia Treatment Gets EU Regulatory Nod; Shares Rise 3%
ABBV,AbbVie Inc,2018-12-06,Intellia nabs $10M from Novartis on expanded partnership
ABBV,AbbVie Inc,2018-12-04,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-12-04,AbbVie's Imbruvica improves survival over chemo in certain CLL/SLL patients
ABBV,AbbVie Inc,2018-12-02,AbbVie and Roche's venetoclax shows long-term treatment benefit in late-stage leukemia study
ABBV,AbbVie Inc,2018-11-30,Stocks - Dow Clinches Monthly Gain Amid Late Rally on Trade Hopes
ABBV,AbbVie Inc,2018-11-30,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.79%
ABBV,AbbVie Inc,2018-11-30,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-11-30,Stocks waver ahead of Trump-Xi meeting at G-20
ABBV,AbbVie Inc,2018-11-23,SunTrust: Venclexta could add $1B+ for AbbVie
ABBV,AbbVie Inc,2018-11-13,AbbVie's Mavyret delivers 100% cure rate in late-stage HCV study
ABBV,AbbVie Inc,2019-01-02,Drug makers OK with price inclusion in TV ads if done fairly
ABBV,AbbVie Inc,2019-01-02,AbbVie Falls 3%
ABBV,AbbVie Inc,2018-12-28,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-12-26,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-12-20,Stocks - Dow's Dour December Continues Amid Turmoil in Washington
ABBV,AbbVie Inc,2018-12-20,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.99%
ABBV,AbbVie Inc,2018-12-20,AbbVie Rises 3%
ABBV,AbbVie Inc,2018-12-13,"Senate Dems introduce bill to block ""excessive"" increases in drug prices"
ABBV,AbbVie Inc,2018-12-07,AbbVie Falls 4%
ABBV,AbbVie Inc,2018-12-06,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-01-16,Hospitals squeezed by high drug costs
ABBV,AbbVie Inc,2019-01-15,FDA to beef up cell and gene therapy staff
ABBV,AbbVie Inc,2019-01-14,U.S. lawmaker launches investigation into pharma drug pricing
ABBV,AbbVie Inc,2019-01-10,Sen. Sanders  Rep. Cummings introduce bill to lower U.S. drug prices
ABBV,AbbVie Inc,2019-01-10,Corvus Pharma to advance CPI-818 into the clinic
ABBV,AbbVie Inc,2019-01-09,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-01-09,Top Picks 2019- AbbVie Inc. ABBV
ABBV,AbbVie Inc,2019-01-04,AbbVie Rises 3%
ABBV,AbbVie Inc,2019-01-03,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-01-02,Drug companies greet 2019 with U.S. price hikes
ABBV,AbbVie Inc,2019-01-28,Orix reports 9M results
ABBV,AbbVie Inc,2019-01-25,Stocks - Dow Logs Triple-Digit Gains as Shutdown Ends
ABBV,AbbVie Inc,2019-01-25,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.75%
ABBV,AbbVie Inc,2019-01-25,AbbVie Falls 6%
ABBV,AbbVie Inc,2019-01-25,Stocks - Colgate  Intel Fall Premarket; Starbucks  Western Digital Jump
ABBV,AbbVie Inc,2019-01-25,AbbVie Earnings  Revenue miss in Q4
ABBV,AbbVie Inc,2019-01-25,Top 5 Things to Know in The Market on Friday
ABBV,AbbVie Inc,2019-01-24,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-01-20,Economic Calendar - Top 5 Things to Watch This Week
ABBV,AbbVie Inc,2019-01-18,AbbVie's Imbruvica flunks late-stage pancreatic cancer study
ABBV,AbbVie Inc,2019-02-12,Boehringer Ingelheim teams up with IBM to explore use of blockchain in clinical trials
ABBV,AbbVie Inc,2019-02-11,AbbVie on go to start clinical development of Parkinson's candidate ABBV-0805
ABBV,AbbVie Inc,2019-02-06,At least four pharma CEOs to testify at Senate drug pricing hearing
ABBV,AbbVie Inc,2019-02-05,Merck CEO Frazier plans to testify at Senate drug pricing hearing
ABBV,AbbVie Inc,2019-02-04,Powerful Senate committee invites pharma executives to testify
ABBV,AbbVie Inc,2019-02-04,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.70%
ABBV,AbbVie Inc,2019-02-04,Stocks - Dow Closes Higher as Tech Stocks Reign Supreme
ABBV,AbbVie Inc,2019-02-04,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-01-30,TG Therapeutics up 7% premarket on positive TG-1101/TGR-1202 data
ABBV,AbbVie Inc,2019-01-28,AbbVie Falls 3%
ABBV,AbbVie Inc,2019-03-19,AbbVie's stock falls 0.8% premarket after FDA places hold on trial of multiple myeloma treatment
ABBV,AbbVie Inc,2019-03-17,2 Things Investors Are Missing About AbbVie
ABBV,AbbVie Inc,2019-03-12,Under The Spotlight: AbbVie
ABBV,AbbVie Inc,2019-03-11,Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
ABBV,AbbVie Inc,2019-03-10,4 Stocks to Buy With Dividends Yielding More Than 4%
ABBV,AbbVie Inc,2019-03-06,Synlogic progressing IBD partnership with AbbVie
ABBV,AbbVie Inc,2019-03-01,European advisory group backs AbbVie's risankizumab for plaque psoriasis
ABBV,AbbVie Inc,2019-02-25,Pharma stocks could see turbulence from U.S. Senate drug-price hearing
ABBV,AbbVie Inc,2019-02-20,Bristol-Myers says Starboard nominated five directors  bought shares
ABBV,AbbVie Inc,2019-02-19,U.S. settles with Teva over keeping generic drugs off market
ABBV,AbbVie Inc,2019-03-24,4 Blockbuster Drug Launches to Watch in 2019
ABBV,AbbVie Inc,2019-03-24,3 Bargain Stocks You Can Buy Today
ABBV,AbbVie Inc,2019-03-24,Where Will AbbVie Be in 10 Years?
ABBV,AbbVie Inc,2019-03-21,Better Buy: AbbVie vs. Eli Lilly
ABBV,AbbVie Inc,2019-03-21,FDA warns on increased mortality risk with AbbVie's Venclexta in MM
ABBV,AbbVie Inc,2019-03-21,Biogen scraps two Alzheimer drug trials  wipes $18 billion from market value
ABBV,AbbVie Inc,2019-03-19,Brainstorm Health: AI and Old Drugs  Gene Editing Registry  AbbVie Cancer Drug
ABBV,AbbVie Inc,2019-03-19,Bad News for AbbVie and Multiple Myeloma Patients
ABBV,AbbVie Inc,2019-03-19,AbbVie down 1% premarket on partial hold on venetoclax
ABBV,AbbVie Inc,2019-03-19,AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myeloma
ABBV,AbbVie Inc,2019-04-14,The Simple Way You Could Make 10% Each Year With AbbVie
ABBV,AbbVie Inc,2019-04-08,Alder poaches AbbVie exec for top commercial job
ABBV,AbbVie Inc,2019-04-02,AbbVie Rises 3%
ABBV,AbbVie Inc,2019-04-01,Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients  with Alzheimer's Disease
ABBV,AbbVie Inc,2019-03-31,Better Buy: AbbVie vs. Johnson & Johnson
ABBV,AbbVie Inc,2019-03-30,3 High-Yield Stocks at Rock-Bottom Prices
ABBV,AbbVie Inc,2019-03-29,Wall Street is buzzing about Gilead’s new rheumatoid arthritis drug. Here’s why
ABBV,AbbVie Inc,2019-03-27,Brainstorm Health: Centene WellCare Deal  AbbVie Approval  Obamacare Decision
ABBV,AbbVie Inc,2019-03-26,The Daily Biotech Pulse: Japanese Cheer For AbbVie  Myokardia Offering  CytomX CFO Departs
ABBV,AbbVie Inc,2019-03-26,AbbVie's SKYRIZI OK'd in Japan
